These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23632018)

  • 1. Folding of a cyclin box: linking multitarget binding to marginal stability, oligomerization, and aggregation of the retinoblastoma tumor suppressor AB pocket domain.
    Chemes LB; Noval MG; Sánchez IE; de Prat-Gay G
    J Biol Chem; 2013 Jun; 288(26):18923-38. PubMed ID: 23632018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7.
    Lee JO; Russo AA; Pavletich NP
    Nature; 1998 Feb; 391(6670):859-65. PubMed ID: 9495340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.
    Dick FA; Sailhamer E; Dyson NJ
    Mol Cell Biol; 2000 May; 20(10):3715-27. PubMed ID: 10779361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.
    Helt AM; Galloway DA
    J Virol; 2001 Aug; 75(15):6737-47. PubMed ID: 11435552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences.
    Singh M; Krajewski M; Mikolajka A; Holak TA
    J Biol Chem; 2005 Nov; 280(45):37868-76. PubMed ID: 16118215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest.
    Nguyen DX; Westbrook TF; McCance DJ
    J Virol; 2002 Jan; 76(2):619-32. PubMed ID: 11752153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting mechanism of the retinoblastoma tumor suppressor by a prototypical viral oncoprotein. Structural modularity, intrinsic disorder and phosphorylation of human papillomavirus E7.
    Chemes LB; Sánchez IE; Smal C; de Prat-Gay G
    FEBS J; 2010 Feb; 277(4):973-88. PubMed ID: 20088881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural similarity between the pocket region of retinoblastoma tumour suppressor and the cyclin-box.
    Kim HY; Cho Y
    Nat Struct Biol; 1997 May; 4(5):390-5. PubMed ID: 9145110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics simulations of retinoblastoma protein.
    Ramakrishnan C; Subramanian V; Balamurugan K; Velmurugan D
    J Biomol Struct Dyn; 2013; 31(11):1277-92. PubMed ID: 23157310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic recognition of the retinoblastoma tumor suppressor by a specific protein target.
    Chemes LB; Sánchez IE; de Prat-Gay G
    J Mol Biol; 2011 Sep; 412(2):267-84. PubMed ID: 21787785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of SV40 large T antigen and other viral proteins with retinoblastoma tumour suppressor.
    Lee C; Cho Y
    Rev Med Virol; 2002; 12(2):81-92. PubMed ID: 11921304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor.
    Liu X; Clements A; Zhao K; Marmorstein R
    J Biol Chem; 2006 Jan; 281(1):578-86. PubMed ID: 16249186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites.
    Knudsen ES; Wang JY
    J Biol Chem; 1996 Apr; 271(14):8313-20. PubMed ID: 8626527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding.
    Burke JR; Deshong AJ; Pelton JG; Rubin SM
    J Biol Chem; 2010 May; 285(21):16286-93. PubMed ID: 20223825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligomerization properties of the viral oncoproteins adenovirus E1A and human papillomavirus E7 and their complexes with the retinoblastoma protein.
    Clements A; Johnston K; Mazzarelli JM; Ricciardi RP; Marmorstein R
    Biochemistry; 2000 Dec; 39(51):16033-45. PubMed ID: 11123931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.
    Iwahori S; Hakki M; Chou S; Kalejta RF
    J Biol Chem; 2015 Aug; 290(32):19666-80. PubMed ID: 26100623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth.
    Sdek P; Ying H; Zheng H; Margulis A; Tang X; Tian K; Xiao ZX
    J Biol Chem; 2004 Dec; 279(51):53317-22. PubMed ID: 15485814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
    Ledl A; Schmidt D; Müller S
    Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.